A detailed history of Mid West One Financial Group, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Mid West One Financial Group, Inc. holds 5,558 shares of UTHR stock, worth $2.04 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
5,558
Previous 6,817 18.47%
Holding current value
$2.04 Million
Previous $2.17 Million 8.29%
% of portfolio
0.28%
Previous 0.4%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $391,599 - $457,709
-1,259 Reduced 18.47%
5,558 $1.99 Million
Q2 2024

Aug 15, 2024

SELL
$228.26 - $319.04 $462,226 - $646,056
-2,025 Reduced 22.9%
6,817 $2.17 Million
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $333,843 - $395,223
1,584 Added 21.82%
8,842 $2.03 Million
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $18,694 - $22,353
87 Added 1.21%
7,258 $1.6 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $324,508 - $380,303
1,532 Added 27.17%
7,171 $1.62 Million
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $86,590 - $98,321
-422 Reduced 6.96%
5,639 $1.24 Million
Q1 2023

May 15, 2023

SELL
$212.99 - $276.17 $31,948 - $41,425
-150 Reduced 2.42%
6,061 $1.36 Million
Q4 2022

Feb 14, 2023

SELL
$205.95 - $280.43 $68,375 - $93,102
-332 Reduced 5.07%
6,211 $1.73 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $143,326 - $172,139
-705 Reduced 9.73%
6,543 $1.37 Million
Q2 2022

Aug 16, 2022

SELL
$174.81 - $241.14 $25,347 - $34,965
-145 Reduced 1.96%
7,248 $1.71 Million
Q1 2022

May 17, 2022

BUY
$166.16 - $213.96 $1.23 Million - $1.58 Million
7,393 New
7,393 $1.33 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mid West One Financial Group, Inc. Portfolio

Follow Mid West One Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mid West One Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mid West One Financial Group, Inc. with notifications on news.